Torrence P F, Kinjo J, Lesiak K, Balzarini J, De Clercq E
Section on Biomedical Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892.
FEBS Lett. 1988 Jul 4;234(1):135-40. doi: 10.1016/0014-5793(88)81319-x.
In an attempt to provide a derivative of 3'-azido-3'-deoxythymidine (AZT) which might be sequestered in the central nervous system and release AZT, the dihydropyridine ester 5'-(1,4-dihydro-1-methyl-3-pyridinylcarbonyl)-3'-deoxythymidine, was synthesized in a three step sequence. This material showed potent anti-HIV-1 activity in MT-4 cells most probably by hydrolysis to the parent nucleoside, AZT. This dihydropyridine derivative of AZT could be easily oxidized to a positively charged pyridinium derivative of AZT in rat brain cytosol. In turn the pyridinium form could be hydrolyzed, non-enzymatically, to AZT.
为了提供一种可能被隔离在中枢神经系统并释放齐多夫定(AZT)的3'-叠氮基-3'-脱氧胸苷(AZT)衍生物,通过三步合成了二氢吡啶酯5'-(1,4-二氢-1-甲基-3-吡啶基羰基)-3'-脱氧胸苷。该物质在MT-4细胞中显示出强大的抗HIV-1活性,很可能是通过水解为母体核苷AZT实现的。AZT的这种二氢吡啶衍生物在大鼠脑细胞质中很容易被氧化为带正电荷的AZT吡啶鎓衍生物。反过来,吡啶鎓形式可以非酶促水解为AZT。